最新报道:CVS Health reported better-than-expected Q2 2025 earnings, with revenue reaching $98.7 billion, up 8% year-over-year, driven by strong performance in its pharmacy services and retail segments. Adjusted EPS came in at $2.45, surpassing analysts' estimates of $2.32. The company raised its full-year guidance, now expecting adjusted EPS between $9.50 and $9.70, citing continued growth in healthcare services and cost management efforts. CEO Karen Lynch highlighted expanded Medicare Advantage offerings and digital health initiatives as key growth drivers. CVS shares rose 3% in premarket trading following the announcement.